A qualified provider will evaluate your health to ensure treatment is appropriate and safe
Supplied strictly for laboratory research, not for human or animal consumption.
Together, they produce a steadier and more sustained release pattern than either peptide alone
"These results support the remarkable potential for people living with type 2 diabetes." In a 40-week Phase 3 randomized, double-blind, placebo-controlled trial for retatrutide, which included 537 participants, the drug showed average A1C reductions of up to 2% and participants lost an average of 36.6 pounds, or roughly 17% weight loss
Our system supports body composition shiftshelping you lose fat and preserve muscle, especially when paired with lifestyle changes that include adequate protein and regular activity.* Reduced visceral fat (the dangerous kind around your organs) , 100% who lost weight did not lose muscle More skeletal muscle gained, more fat lost , Average weight loss of 12 pounds per week, up to 25 pounds in 12 weeks Confidence comes from feeling more comfortable in your skin (and your clothes)
Warnings and precautions: Consider the risk of aspiration during general anaesthesia or deep sedation